HPV Vaccination Significantly Lowers Cervical and Vulvovaginal Cancer Risks
A study in Denmark shows that HPV vaccination has drastically reduced the prevalence of oncogenic HPV16/18 strains from 16% to less than 1%, highlighting the vaccine's effectiveness in preventing HPV-related cancers. The article discusses the commonality of HPV, transmission methods, the importance of vaccination regardless of infection history, and debates around vaccination timing and policies.